Evidence map›Paper›PMID 25117538›Full record

ArticleAmerican journal of men's health2015

Getting Black Men to Undergo Prostate Cancer Screening: The Role of Social Capital.

Lorraine T Dean, S V Subramanian, David R Williams, Katrina Armstrong, Camille Zubrinsky Charles, Ichiro Kawachi

Open access · greenAbstract read
In one paragraph

Article in American journal of men's health, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 3 pooled it
4.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 3 syntheses or guidelines pooled it, 44 citations in OpenAlex.

  1. A Model-Based Meta-Analysis of Willingness to Participate in Cancer Screening.International journal of environmental research and public health · 2021
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Engaging African American Men as Citizen Scientists to Validate a Prostate Cancer Biomarker: Work-in-Progress.Progress in community health partnerships : research, education, and action · 2019
    Article
  15. Review
  16. The association between physician trust and prostate-specific antigen screening: Implications for shared decision-making.Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2018
    Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Lorraine T DeanSchool of Medicine, University of Pennsylvania, Philadelphia, PA, USA ldean@post.harvard.edu.
S V SubramanianHarvard School of Public Health, Boston, MA, USA.
David R WilliamsHarvard School of Public Health, Boston, MA, USA.
Katrina ArmstrongMassachusetts General Hospital, Boston, MA, USA.
Camille Zubrinsky CharlesSchool of Arts and Sciences, University of Pennsylvania, Philadelphia, PA, USA.
Ichiro KawachiHarvard School of Public Health, Boston, MA, USA.
Harvard University · USUniversity of Pennsylvania · USMassachusetts General Hospital · US

Funding

Social Determinants of Breast Cancer SurvivorshipK01CA184288 · NCI · UNIVERSITY OF PENNSYLVANIA · PI DEAN, LORRAINE TIERA · 2014 to 2018
$767k
Cancer prevention, mental health and social capital of segregated Black AmericansF31CA136236 · NCI · HARVARD SCHOOL OF PUBLIC HEALTH · PI DEAN, LORRAINE TIERA · 2008 to 2010
$41k
NCI NIH HHS 1F31CA136236NCI NIH HHS F31 CA136236NCI NIH HHS K01 CA184288
6 · The paper itself

Abstract

Despite higher rates of prostate cancer-related mortality and later stage of prostate cancer diagnosis, Black/African American men are significantly less likely than non-Hispanic White men to use early detection screening tools, like prostate-specific antigen (PSA) testing for prostate cancer. Lower screening rates may be due, in part, to controversy over the value of prostate cancer screenings as part of routine preventive care for men, but Black men represent a high-risk group for prostate cancer that may still benefit from PSA testing. Exploring the role of social factors that might be associated with PSA testing can increase knowledge of what might promote screening behaviors for prostate cancer and other health conditions for which Black men are at high risk. Using multilevel logistic regression, this study analyzed self-report lifetime use of PSA test for 829 Black men older than 45 years across 381 Philadelphia census tracts. This study included individual demographic and aggregated social capital data from the Public Health Management Corporation's 2004, 2006, and 2008 waves of the Community Health Database, and sociodemographic characteristics from the 2000 U.S. Census. Each unit increase in community participation was associated with a 3 to 3.5 times greater likelihood of having had a PSA test (odds ratio = 3.35). Findings suggest that structural forms of social capital may play a role in screening behaviors for Black men in Philadelphia. A better understanding of the mechanism underlying the link between social capital and screening behaviors can inform how researchers and interventionists develop tools to promote screening for those who need it.

Indexed as

Black PeopleCommunity ParticipationSocial CapitalAge FactorsBlack or African AmericanHealth SurveysHumansIncomeInsurance CoverageInsurance, HealthMaleMass ScreeningMiddle AgedMultivariate AnalysisPhiladelphiaProstate-Specific AntigenProstate-Specific AntigenBlack/African American mencommunity participationPhiladelphiaprostate cancerprostate-specific antigen (PSA)screeningsocial capital

Identifiers

PMID25117538
PMCPMC4472568
OpenAlexW2071077898

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.